GE B125B105 Patient Monitor Singapore - English - HSA (Health Sciences Authority)

ge b125b105 patient monitor

ge healthcare pte. ltd. - general hospital - portable multi-parameter unit to be used for monitoring and recording of, and to generate alarms for multiple physiological parameters of adult, pediatric, and neonatal patients in a hospital environment and during intra-hospital transport. intended for use under the direct supervision of a licensed health care practitioner. not intended for use during mri. monitor can be a stand-alone monitor or interfaced to other devices via network. the monitors and displays: ecg, invasive blood pressure, heart/pulse rate, oscillometric non-invasive blood pressure functional oxygen saturation (spo2) and pulse rate via continuous monitoring(including monitoring during conditions of clinical patient motion or low perfusion), temperature with a reusable or disposable electronic thermometer for continual monitoring esophageal/nasopharyngeal/tympanic/rectal/bladder/axillary/skin/airway/room/myocardial/ core/surface temperature, impedance respiration, respiration rate, airway gases, c.o. and entrophy.

GE Infinia Singapore - English - HSA (Health Sciences Authority)

ge infinia

ge healthcare pte. ltd. - radiology / imaging - the infinia system is intended for whole body general nuclear medicine imaging applications in patients of all ages.

GE iVent 201 Singapore - English - HSA (Health Sciences Authority)

ge ivent 201

ge healthcare pte. ltd. - anaesthesiology - a portable, computer controlled, electrically powered intensive care ventilator intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation. it is applicable for use with adult through pediatric patients, who require invasive or non-invasive assistance via the following general modes of ventilatory support, as prescribed by an attending physician: • assist/control (pressure controlled or volume controlled) • simv (pressure controlled or volume controlled) • cpap/psv suitable for use in the icu and all other hospital areas, in all hospital-type facilities,alternate care sites, transport,emergency and in the home environment. the non-invasive pulse oximeter is intended for non-invasive monitoring of oxygen saturation and pulse rate, suitable for use in all above mentioned areas,excluding mr environments. it is a restricted device intended for use by qualified, trained personnel under physician supervision.

MYOVIEW FOR INJECTION 0.23 mgvial Singapore - English - HSA (Health Sciences Authority)

myoview for injection 0.23 mgvial

ge healthcare pte. ltd. - tetrofosmin (as tetrofosmin sulphosalicylate) - injection, powder, for solution - 0.23 mg/vial - tetrofosmin (as tetrofosmin sulphosalicylate) 0.23 mg/vial

SHINGRIX- zoster vaccine recombinant, adjuvanted kit United States - English - NLM (National Library of Medicine)

shingrix- zoster vaccine recombinant, adjuvanted kit

glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e antigen (unii: cob9ff6i46) (recombinant varicella zoster virus glycoprotein e antigen - unii:cob9ff6i46) - ge: recombinant varicella zoster virus (vzv) glycoprotein e 50 ug in 0.5 ml - shingrix is a vaccine indicated for prevention of herpes zoster (hz) (shingles):     •    in adults aged 50 years and older.     •    in adults aged 18 years and older who are or will be at increased risk of hz due to immunodeficiency or immunosuppression caused by known disease or therapy. limitations of use : do not administer shingrix to anyone with a history of a severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine or after a previous dose of shingrix [see description (11)] . risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. the data are insufficient to establish if there is vaccine-associated risk with shingrix in pregnant women. a developmental toxicity study was performed in female rats administered shingrix or the as01b adjuvant alone prior to mating, during g

OMNIPAQUE INJECTION 300 mg Iml Singapore - English - HSA (Health Sciences Authority)

omnipaque injection 300 mg iml

ge healthcare pte. ltd. - iohexol 647 mg/ml eqv iodine - injection - 300 mg/ml - iohexol 647 mg/ml eqv iodine 300 mg/ml

OMNIPAQUE INJECTION 350 mg Iml Singapore - English - HSA (Health Sciences Authority)

omnipaque injection 350 mg iml

ge healthcare pte. ltd. - iohexol 755 mg/ml eqv iodine - injection - 350 mg/ml - iohexol 755 mg/ml eqv iodine 350 mg/ml

Teslascan European Union - English - EMA (European Medicines Agency)

teslascan

ge healthcare as - mangafodipir trisodium - magnetic resonance imaging - contrast media - this medicinal product is for diagnostic use only.contrast medium for diagnostic magnetic resonance imaging (mri) for the detection of lesions of the liver suspected to be due to metastatic disease or hepatocellular carcinomas. as an adjunct to mri to aid in the investigation of focal pancreatic lesions.

MYOVIEW kit for the preparation of technetium [99cm Tc] tetrofosmin injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

myoview kit for the preparation of technetium [99cm tc] tetrofosmin injection vial

ge healthcare australia pty ltd - tetrofosmin, quantity: 0.23 mg; stannous chloride dihydrate, quantity: 0.03 mg - injection, solution - excipient ingredients: sodium bicarbonate; sodium gluconate; disodium sulfosalicylate - myoview is indicated as an adjunct in the diagnosis of ischaemic heart disease infarction.

CERETEC kit for preparation of technetium (99mTc) exametazime powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

ceretec kit for preparation of technetium (99mtc) exametazime powder for injection vial

ge healthcare australia pty ltd - exametazime, quantity: 0.5 mg - injection, powder for - excipient ingredients: sodium chloride; stannous chloride dihydrate - for use in the preparation of technetium tc 99m exametazime for intravenous administration in specialised units for scintigraphic localisation of seizure foci in patients with temporal lobe epilepsy.